Arnold Louie
About
Arnold Louie is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases.
According to data from OpenAlex, Arnold Louie has authored 121 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pharmacology, 67 papers in Molecular Medicine and 49 papers in Infectious Diseases. Recurrent topics in Arnold Louie's work include Antibiotics Pharmacokinetics and Efficacy (69 papers), Antibiotic Resistance in Bacteria (67 papers) and Tuberculosis Research and Epidemiology (20 papers). Arnold Louie is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (69 papers), Antibiotic Resistance in Bacteria (67 papers) and Tuberculosis Research and Epidemiology (20 papers). Arnold Louie collaborates with scholars based in United States, United Kingdom and Australia. Arnold Louie's co-authors include George L. Drusano, Weiguo Liu, Tawanda Gumbo, Mark R. Deziel, Paul G. Ambrose, Sujata M. Bhavnani, Robert Kulawy, Vincent H. Tam, Michael H. Miller and Alan Forrest and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Clinical Infectious Diseases.
In The Last Decade
Arnold Louie
120 papers receiving 5.5k citations
Hit Papers
Peers
Arnold Louie
Michael N. Dudley United States
Brian T. Tsuji United States
Paul G. Ambrose United States
Craig R. Rayner United States
Jürgen B. Bulitta United States
Sujata M. Bhavnani United States
M. Hong Nguyen United States
Ryan K. Shields United States
Philippe Lagacé‐Wiens Canada
Joyce A. Sutcliffe United States
Citations per year, relative to Arnold Louie Arnold Louie (= 1×)
peers
Michael N. Dudley
Countries citing papers authored by Arnold Louie
Since
Specialization
Citations
This map shows the geographic impact of Arnold Louie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Louie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Louie more than expected).
Fields of papers citing papers by Arnold Louie
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Arnold Louie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Louie. The network helps show where Arnold Louie may publish in the future.
Co-authorship network of co-authors of Arnold Louie
This figure shows the co-authorship network connecting the top 25 collaborators of Arnold Louie. A scholar is included among the top collaborators of Arnold Louie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold Louie. Arnold Louie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Singh, Nidhi, Jeremy J. Johnson, Arnold Louie, et al.. (2025). Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection model. Journal of Antimicrobial Chemotherapy. 80(5). 1309–1314.
2.
Jiao, Yuanyuan, Jun Yan, Dhruvitkumar S. Sutaria, et al.. (2024). Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models. Antimicrobial Agents and Chemotherapy. 68(3). e0139423–e0139423.
3.
Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2023). Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model. Frontiers in Pharmacology. 14. 1291885–1291885.
4.
Jiao, Yuanyuan, Jun Yan, Michael Vicchiarelli, et al.. (2023). Individual Components of Polymyxin B Modeled via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice. Antimicrobial Agents and Chemotherapy. 67(5). e0019723–e0019723.
5.
Jacobsson, Susanne, Daniel Golparian, Joakim Oxelbark, et al.. (2022). Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model. Frontiers in Pharmacology. 13. 874176–874176.
6.
Drusano, George L., Robert A. Bonomo, Laura J. Rojas, et al.. (2021). Emergence of Resistance to Ceftazidime-Avibactam in a Pseudomonas aeruginosa Isolate Producing Derepressed bla PDC in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 65(6).
7.
Kim, Sarah, Arnold Louie, George L. Drusano, et al.. (2021). Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid. International Journal of Antimicrobial Agents. 59(2). 106509–106509.
8.
Kim, Tae Hwan, Xun Tao, Bartolomé Moyá, et al.. (2020). Novel Cassette Assay To Quantify the Outer Membrane Permeability of Five β-Lactams Simultaneously in Carbapenem-ResistantKlebsiella pneumoniaeandEnterobacter cloacae. mBio. 11(1).
9.
Bulitta, Jürgen B., William Hope, Ann E. Eakin, et al.. (2019). Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans. Antimicrobial Agents and Chemotherapy. 63(5).
10.
Jiao, Yuanyuan, Bartolomé Moyá, Alexandre Prehn Zavascki, et al.. (2019). Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials. Antimicrobial Agents and Chemotherapy. 63(7).
11.
Sutaria, Dhruvitkumar S., Bartolomé Moyá, Kari B. Green, et al.. (2018). First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 62(6).
12.
Louie, Arnold, et al.. (2010). The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression. Antimicrobial Agents and Chemotherapy. 54(6). 2646–2654.
13.
Louie, Arnold, Henry S. Heine, Kiho Kim, et al.. (2008). Use of an In Vitro Pharmacodynamic Model To Derive a Linezolid Regimen That Optimizes Bacterial Kill and Prevents Emergence of Resistance in Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 52(7). 2486–2496.
14.
Louie, Arnold, David Brown, Weiguo Liu, et al.. (2007). In Vitro Infection Model Characterizing the Effect of Efflux Pump Inhibition on Prevention of Resistance to Levofloxacin and Ciprofloxacin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 51(11). 3988–4000.
15.
Gumbo, Tawanda, Arnold Louie, Mark R. Deziel, et al.. (2007). Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin. Antimicrobial Agents and Chemotherapy. 51(11). 3781–3788.
16.
Gumbo, Tawanda, Arnold Louie, Weiguo Liu, et al.. (2006). Isoniazid’s Bactericidal Activity Ceases because of the Emergence of Resistance, Not Depletion ofMycobacterium tuberculosisin the Log Phase of Growth. The Journal of Infectious Diseases. 195(2). 194–201.
17.
Louie, Arnold, Mark R. Deziel, Weiguo Liu, et al.. (2005). Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity. Antimicrobial Agents and Chemotherapy. 49(12). 5058–5068.
18.
Hope, William, Peter Warn, Joanne Sharp, et al.. (2005). Surface Response Modeling to Examine the Combination of Amphotericin B Deoxycholate and 5‐Fluorocytosine for Treatment of Invasive Candidiasis. The Journal of Infectious Diseases. 192(4). 673–680.
19.
Mayers, Martin, et al.. (1998). Comparison of Fluconazole Pharmacokinetics in Serum, Aqueous Humor, Vitreous Humor, and Cerebrospinal Fluid Following a Single Dose and at Steady State. Journal of Ocular Pharmacology and Therapeutics. 14(5). 459–471.
20.
Louie, Arnold, Aldona L. Baltch, M. Franke, et al.. (1996). Effect of pentoxifylline on the course of systemic Candida albicans infection in mice. Journal of Antimicrobial Chemotherapy. 37(5). 943–954.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Michael N. Dudley Breakdown of academic impact, for papers by Brian T. Tsuji Breakdown of academic impact, for papers by Paul G. Ambrose Breakdown of academic impact, for papers by Craig R. Rayner Breakdown of academic impact, for papers by Jürgen B. Bulitta Breakdown of academic impact, for papers by Sujata M. Bhavnani Breakdown of academic impact, for papers by M. Hong Nguyen Breakdown of academic impact, for papers by Ryan K. Shields Breakdown of academic impact, for papers by Philippe Lagacé‐Wiens Breakdown of academic impact, for papers by Joyce A. Sutcliffe